Trial intelligence / Profile preview

Lactobacillus reuteri Lozenges as Adjunct to Non-surgical Periodontal Therapy in Chronic Periodontitis

TCTR20141028001Phase 4Completed

Sponsor
BioGaia AB
Start
Sep 2012
Modality
Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Countries
1
01

Overview

A Phase 4 trial of lactobacillus reuteri in chronic periodontitis, sponsored by BioGaia AB. Started Sep 2012; status: completed.

02

Drugs

lactobacillus reuteri
03

Conditions

chronic periodontitis

Beyond the preview

Go deeper on TCTR20141028001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20141028001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call